Windtree (WINT), a Nasdaq-listed biopharmaceutical firm, is entrusting Kraken with the custody, trading, and OTC (over-the-counter) trading of its BNB holdings, as reported by CoinDesk. This move follows Windtree's announcement of raising up to $200 million for BNB investment ventures. So far, Windtree has secured $60 million and anticipates raising another $140 million. Partnering with a reputable exchange like Kraken to manage BNB assets offers Windtree enhanced security and potentially better execution on large trades through Kraken's OTC desk. It also signals a growing acceptance of cryptocurrency investment strategies within more traditional sectors. This arrangement could pave the way for other publicly traded companies to explore similar crypto-related investments. ```